The Only Treatment Against Vaginal Atrophy Symptoms Supported by Clinical Studies
SYMPTOMS IMPROVEMENT (%) AFTER 3 MONALISA TOUCH® TREATMENTS IN MENOPAUSE PATIENTS
*Courtesy of Prof. S.Salvatore – Hospital San Raffaele, Milan (Italy)
Vaginal atrophy is a very common condition, especially among women in menopause (either natural or induced) or during post-partum. The vulvovaginal region is very sensitive to estrogen decline, with a series of consequences that impact directly on the quality of a woman’s life: weakness and laxity of the vaginal mucosa, dryness, itching and burning, pain during sexual intercourse (dyspareunia).
MonaLisa Touch ® is the only procedure proven not only by clinical results but also by detailed ultrastructural and histological studies. Scientific publications of the results demonstrate the effective tissue regeneration achieved thanks to the unique combination of the wavelength of the CO2 laser, the structure of the D-Pulse and adequate emission power.
With MonaLisa Touch ® comes a method, with a unique concept, for restoring the trophic conditions of the vulvovaginal region.
During menopause, the mucosa presents a particular condition with metabolically quiescent fibrocytes as opposed to fibroblasts, unable to actively produce collagen, hyaluronic acid and other molecules needed for an adequate glycoprotein ground matrix. This can result in dry mucosa because it is dehydrated and less well nourished meaning it is fragile and more prone to infections.
MonaLisa Touch® – The New Laser Against Vaginal Atrophy, Laxity and Urinary Incontinence
With low water content in the connective tissue, both nutrients and lymphocyte defenses, which get to the lamina propria via the blood vessels, find it harder to migrate through the connective tissue matrix to reach the epithelium. Without nourishment, the epithelium thins, which reduces the shedding of superficial cells, resulting in decreased glycogen in the vaginal lumen. Numbers of lactobacilli, which feed on glycogen and serve to maintain proper acidity in the vaginal environment, are therefore reduced. The pH thus increases, favoring attacks by pathogenic bacteria and the onset of infections.
So the purpose of treating vaginal atrophy is to promote and recover pre-menopausal metabolic activity by means of a new synthesis not only of collagen, but also of hyaluronic acid, glycosaminoglycans and proteoglycans. This helps to regain hydrated mucosa that in turn restores a proper trophic supply to the tissues, thus reinstating all the functions typical of younger healthy tissue.
SYMPTOMS IMPROVEMENT (%) 2 MONTHS AFTER 1 MONALISA TOUCH® TREATMENT IN ONCOLOGICAL PATIENTS
*Courtesy Dr. M. Filippini – Head of Endoscopic Gynecology Dept. of State Hospital – San Marino Republic.
Vaginal laxity, urinary incontinence, dyspareunia, vaginal dryness.
A mini-invasive treatment to improve the quality of life
Login to the scientific area to discover some clinical tools.